Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Sakai

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Journal of Diabetes Research|November 30, 2019
Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney DiseaseKazuo Kobayashi, Masao Toyoda, Noriko Kaneyama, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 17, 2023
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney diseaseShunichiro Tsukamoto, Kazuo Kobayashi, Masao Toyoda, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 31, 2018
Renal effects of sodium glucose co-transporter 2 inhibitors in Japanese type 2 diabetes mellitus patients with home blood pressure monitoringKazuo Kobayashi, Masao Toyoda, Moritsugu Kimura, et al.
Diabetes & Vascular Disease Research|October 5, 2018
Retrospective analysis of effects of sodium-glucose co-transporter 2 inhibitor in Japanese type 2 diabetes mellitus patients with chronic kidney diseaseKazuo Kobayashi, Masao Toyoda, Moritsugu Kimura, et al.
Auris, Nasus, Larynx|May 27, 2026
Prevalence of birch pollinosis and oral allergy syndrome in the general population of Hokkaido, JapanRyuta Kamekura, Takumi Kumai, Masanobu Suzuki, et al.
Cardiovascular Endocrinology & Metabolism|October 2, 2023
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonistsKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.
Diabetes Research and Clinical Practice|February 8, 2022
Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonistsKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.
Journal of Diabetes Investigation|June 8, 2020
Blood pressure after treatment with sodium-glucose cotransporter 2 inhibitors influences renal composite outcome: Analysis using propensity score-matched modelsKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.
Diabetes Technology & Therapeutics|July 30, 2020
Retrospective Analysis of the Renoprotective Effects of Long-Term Use of Six Types of Sodium-Glucose Cotransporter 2 Inhibitors in Japanese Patients with Type 2 Diabetes Mellitus and Chronic Kidney DiseaseKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2019
HLA-DQ and RBFOX1 as susceptibility genes for an outbreak of hydrolyzed wheat allergyEmiko Noguchi, Masato Akiyama, Akiko Yagami, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Journal of Diabetes Research|November 30, 2019
Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney DiseaseKazuo Kobayashi, Masao Toyoda, Noriko Kaneyama, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 17, 2023
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney diseaseShunichiro Tsukamoto, Kazuo Kobayashi, Masao Toyoda, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 31, 2018
Renal effects of sodium glucose co-transporter 2 inhibitors in Japanese type 2 diabetes mellitus patients with home blood pressure monitoringKazuo Kobayashi, Masao Toyoda, Moritsugu Kimura, et al.
Diabetes & Vascular Disease Research|October 5, 2018
Retrospective analysis of effects of sodium-glucose co-transporter 2 inhibitor in Japanese type 2 diabetes mellitus patients with chronic kidney diseaseKazuo Kobayashi, Masao Toyoda, Moritsugu Kimura, et al.
Auris, Nasus, Larynx|May 27, 2026
Prevalence of birch pollinosis and oral allergy syndrome in the general population of Hokkaido, JapanRyuta Kamekura, Takumi Kumai, Masanobu Suzuki, et al.
Cardiovascular Endocrinology & Metabolism|October 2, 2023
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonistsKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.
Diabetes Research and Clinical Practice|February 8, 2022
Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonistsKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.
Journal of Diabetes Investigation|June 8, 2020
Blood pressure after treatment with sodium-glucose cotransporter 2 inhibitors influences renal composite outcome: Analysis using propensity score-matched modelsKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.
Diabetes Technology & Therapeutics|July 30, 2020
Retrospective Analysis of the Renoprotective Effects of Long-Term Use of Six Types of Sodium-Glucose Cotransporter 2 Inhibitors in Japanese Patients with Type 2 Diabetes Mellitus and Chronic Kidney DiseaseKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2019
HLA-DQ and RBFOX1 as susceptibility genes for an outbreak of hydrolyzed wheat allergyEmiko Noguchi, Masato Akiyama, Akiko Yagami, et al.
Pageof 10